Suchergebnisse - "Rosella, Gennaro"

PubPharm (13)

1

Comparison of SB2-Infliximab With Originator-Infliximab in the Measurement of Serum Concentrations : A Short Communication

enthalten in: Therapeutic drug monitoring | 2021

von Ward, M. | Rosella, O. | Rosella, G. | +2

2

Effect of Gluten Ingestion and FODMAP Restriction on Intestinal Epithelial Integrity in Patients with Irritable Bowel Syndrome and Self-Reported Non-Coeliac Gluten Sensitivity

enthalten in: Molecular nutrition & food research | 2021

von Ajamian, M. | Rosella, G. | Newnham, E. | +3

3

Effect of Gluten Ingestion and FODMAP Restriction on Intestinal Epithelial Integrity in Patients with Irritable Bowel Syndrome and Self‐Reported Non‐Coeliac Gluten Sensitivity

enthalten in: Molecular Nutrition & Food Research | 2021

von Ajamian, M. | Rosella, G. | Newnham, E. | +3

4

Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Flanagan, E. | Gibson, P. | Wright, E. | +19

5

Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

enthalten in: Alimentary Pharmacology & Therapeutics | 2020

von Flanagan, E. | Gibson, P. | Wright, E. | +18

6

Serum zonulin as a marker of intestinal mucosal barrier function : May not be what it seems

enthalten in: PloS one | 2019

von Ajamian, M. | Steer, D. | Rosella, G. | +1

7

Letter : vedolizumab drug concentrations in neonates following intrauterine exposure

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Flanagan, E. | Gibson, P. | Begun, J. | +6

CommentOn: Aliment Pharmacol Ther. 2017 Apr;45(7):941-950. - PMID 28169436

8

Evaluation of a 12-week targeted vitamin D supplementation regimen in patients with active inflammatory bowel disease

enthalten in: Clinical nutrition (Edinburgh, Scotland) | 2018

von Garg, M. | Rosella, O. | Rosella, G. | +3

9

Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis : A Prospective Pilot Study

enthalten in: Journal of Crohn's & colitis | 2018

von Beswick, L. | Rosella, O. | Rosella, G. | +4

10

Letter : vedolizumab drug concentrations in neonates following intrauterine exposure

enthalten in: Alimentary Pharmacology & Therapeutics | 2018

von Flanagan, E. | Gibson, P. | Begun, J. | +6